Julia Jedamzik
Overview
Explore the profile of Julia Jedamzik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nixdorf L, Hartl L, Strohl S, Felsenreich D, Mairinger M, Jedamzik J, et al.
Sci Rep
. 2024 Jul;
14(1):17558.
PMID: 39080285
Metabolic dysfunction-associated steatotic liver disease (MASLD) and related steatohepatitis (MASH) are common among obese patients and may improve after metabolic/bariatric surgery (MBS). 93 Patients undergoing MBS in 2021-2022 were prospectively...
2.
Bauer D, Nixdorf L, Dominik N, Schwarz M, Hofer B, Hartl L, et al.
Aliment Pharmacol Ther
. 2024 May;
60(1):70-82.
PMID: 38693718
Background: Obesity impacts the diagnostic accuracy of shear wave elastography (SWE). A deep abdominal ultrasound transducer (DAX) capable of point (pSWE) and two-dimensional (2D)-SWE has recently been introduced to address...
3.
Beirow K, Jedamzik J, Schulig L, Wurm K, Lemmerhirt C, Hofstetter R, et al.
ChemMedChem
. 2023 May;
18(14):e202300145.
PMID: 37170841
Flupirtine and retigabine were essential drugs to combat pain and epilepsy. However, the K 7 potassium channel openers are fraught with hepatotoxicity and tissue discoloration, respectively, limiting their therapeutic value....
4.
Felsenreich D, Arnoldner M, Jedamzik J, Prager G
Surg Obes Relat Dis
. 2023 Feb;
19(4):396-397.
PMID: 36788047
No abstract available.
5.
Jedamzik J, Bichler C, Felsenreich D, Brugger J, Eichelter J, Nixdorf L, et al.
Surg Obes Relat Dis
. 2023 Feb;
19(7):699-705.
PMID: 36740523
Background: Male obesity secondary hypogonadism (MOSH) is a common disease among men with obesity and can be associated with metabolic syndrome and a variety of metabolic problems ultimately leading to...
6.
Felsenreich D, Arnoldner M, Wintersteller L, Mrekva A, Jedamzik J, Eichelter J, et al.
Surg Obes Relat Dis
. 2022 Dec;
19(5):492-499.
PMID: 36566133
Background: Currently, 4.8% of bariatric operations worldwide are one-anastomosis gastric bypass (OAGB) procedures. If a hiatal hernia is detected in a preoperative gastroscopy, OAGB can be combined with hiatoplasty. Intrathoracic...
7.
The ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis?
De Simone B, Abu-Zidan F, Chouillard E, Di Saverio S, Sartelli M, Podda M, et al.
World J Emerg Surg
. 2022 Dec;
17(1):61.
PMID: 36527038
Background: The incidence of the highly morbid and potentially lethal gangrenous cholecystitis was reportedly increased during the COVID-19 pandemic. The aim of the ChoCO-W study was to compare the clinical...
8.
Nixdorf L, Felsenreich D, Bichler C, Jedamzik J, Eichelter J, Gensthaler L, et al.
Surg Technol Int
. 2022 Nov;
41:155-160.
PMID: 36413791
Laparoscopic Roux-en-Y Gastric Bypass (RYGB) is a commonly used method in bariatric surgery that leads to sufficient long-term weight loss and consequently to improvement or resolution of obesity-associated diseases. The...
9.
Felsenreich D, Artemiou E, Wintersteller L, Jedamzik J, Eichelter J, Gensthaler L, et al.
Obes Facts
. 2022 Jul;
15(5):666-673.
PMID: 35882187
Introduction: Sleeve gastrectomy (SG) is the most common bariatric operation with over 340,000 procedures per year. There are only few studies presenting follow-up results >10 years in the literature today....
10.
Felsenreich D, Jedamzik J, Langer F, Prager G
Obes Surg
. 2022 May;
32(8):2793-2794.
PMID: 35641713
No abstract available.